project id: TCGA-LIHC; case submitter id: TCGA-BC-A5W4; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 9.0; age at index: 69; days to birth: -25503; days to death: 547; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1943; age at diagnosis: 25503; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 289.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: Not Reported; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 224; days to sample procurement: 0; initial weight: 540.0; portion submitter id: TCGA-BC-A5W4-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 3.0; percent stromal cells: 7.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0;